牛叉诊股

[{"date":"2026.03.26","stock":"-2.34","trade":"-0.80","ind":"-1.41"},{"date":"2026.03.25","stock":"2.22","trade":"1.38","ind":"1.95"},{"date":"2026.03.24","stock":"3.99","trade":"3.44","ind":"1.43"},{"date":"2026.03.23","stock":"-5.05","trade":"-5.85","ind":"-3.76"},{"date":"2026.03.20","stock":"-1.74","trade":"-1.99","ind":"-0.25"},{"date":"2026.03.19","stock":"-2.81","trade":"-1.92","ind":"-2.02"},{"date":"2026.03.18","stock":"2.81","trade":"0.39","ind":"1.05"},{"date":"2026.03.17","stock":"-0.17","trade":"-0.68","ind":"-1.87"},{"date":"2026.03.16","stock":"0.66","trade":"0.40","ind":"0.19"},{"date":"2026.03.13","stock":"-1.07","trade":"-0.37","ind":"-0.65"},{"date":"2026.03.12","stock":"-0.49","trade":"-0.63","ind":"-0.63"},{"date":"2026.03.11","stock":"-0.89","trade":"-0.35","ind":"0.78"},{"date":"2026.03.10","stock":"3.44","trade":"1.42","ind":"2.04"},{"date":"2026.03.09","stock":"-3.32","trade":"-0.27","ind":"-0.74"},{"date":"2026.03.06","stock":"4.05","trade":"1.93","ind":"0.59"},{"date":"2026.03.05","stock":"4.04","trade":"0.54","ind":"1.23"},{"date":"2026.03.04","stock":"0.97","trade":"-1.09","ind":"-0.75"},{"date":"2026.03.03","stock":"-4.81","trade":"-1.58","ind":"-3.07"},{"date":"2026.03.02","stock":"-2.79","trade":"-2.12","ind":"-0.20"},{"date":"2026.02.27","stock":"-1.13","trade":"0.36","ind":"-0.06"},{"date":"2026.02.26","stock":"-0.24","trade":"-0.47","ind":"0.19"}]

古汉医药,深证成指,中药指数

压力支撑

该股压力位为11.82元，支撑位为11.49元。

[{"text":"\u538b\u529b\u4f4d","value":"11.82","date":1774454400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.49","date":1774454400,"color":"0x0b52a1"}]

多空趋势

多头行情中，并且有加速上涨趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：2.9资金面打败了23%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：03月26日 16:52

机构今日流向(万元)	-1182.77	机构5日流向(万元)	-2913.12
机构10日流向(万元)	-5538.86	机构20日流向(万元)	-11478.06

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加82.13万股，其中基金数没有增加，主力净减仓6家，暂未发现中长期投资价值。

截止2025-06-30，共7家主力机构（一般法人4家，基金3家），持仓量总计11012.73万股，占流通A股46.01%
其中，基金持仓与2024-12-31相比：
增仓：1家，增持 2.16万股
减仓：1家，减持 0.72万股
新出现在主力名单中：2家，持有118.74万股
从主力名单中消失：8家，原持有38.05万股

消息面诊股

诊断结果：6.9消息面打败了75%的股票今日有利好新闻的公司

近期该股利好消息较多，投资者可加强关注。

消息面得分最高的股票

消息列表

利好	业绩预告	预计减亏	2026-01-30
一般消息	重大事项	关联交易	2026-01-17
一般消息	股东大会	临时股东大会	2025-12-31
一般消息	重大事项	关联交易	2025-12-31
一般消息	重大事项	关联交易	2025-11-19
一般消息	高管变动	工作原因	2025-11-18
一般消息	重大事项	公司股东股份解押	2025-10-24
一般消息	高管变动	因工作变动	2025-09-22
一般消息	高管变动	因工作变动	2025-08-30
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	资产重组	公司股权转让	2025-08-13
一般消息	分红转增	不分配不转增	2025-03-28

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：6.0行业面打败了87%的股票中药行业最新资金流向

近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，接近大盘。

[{"date":"2026.03.26","price":"-1.41","value":"-0.80"},{"date":"2026.03.25","price":"1.95","value":"1.38"},{"date":"2026.03.24","price":"1.43","value":"3.44"},{"date":"2026.03.23","price":"-3.76","value":"-5.85"},{"date":"2026.03.20","price":"-0.25","value":"-1.99"},{"date":"2026.03.19","price":"-2.02","value":"-1.92"},{"date":"2026.03.18","price":"1.05","value":"0.39"},{"date":"2026.03.17","price":"-1.87","value":"-0.68"},{"date":"2026.03.16","price":"0.19","value":"0.40"},{"date":"2026.03.13","price":"-0.65","value":"-0.37"},{"date":"2026.03.12","price":"-0.63","value":"-0.63"},{"date":"2026.03.11","price":"0.78","value":"-0.35"},{"date":"2026.03.10","price":"2.04","value":"1.42"},{"date":"2026.03.09","price":"-0.74","value":"-0.27"},{"date":"2026.03.06","price":"0.59","value":"1.93"},{"date":"2026.03.05","price":"1.23","value":"0.54"},{"date":"2026.03.04","price":"-0.75","value":"-1.09"},{"date":"2026.03.03","price":"-3.07","value":"-1.58"},{"date":"2026.03.02","price":"-0.20","value":"-2.12"},{"date":"2026.02.27","price":"-0.06","value":"0.36"},{"date":"2026.02.26","price":"0.19","value":"-0.47"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	25.90%	25.90%	6.9分
2	嘉应制药	6.64%	0.26%	5.5分
3	华润江中	3.94%	0.98%	6.4分
4	东阿阿胶	3.24%	6.31%	6.8分
5	羚锐制药	2.37%	0.00%	6.3分
6	康惠股份	2.02%	-0.80%	5.8分
7	达仁堂	1.25%	3.94%	6.1分
8	健民集团	-0.46%	4.02%	6.1分
9	振东制药	-2.45%	1.70%	5.7分
10	华润三九	-2.51%	-3.91%	6.0分
11	九芝堂	-2.56%	-1.91%	5.5分
12	ST百灵	-2.87%	-3.67%	4.8分
13	天目药业	-2.93%	1.26%	6.5分
14	桂林三金	-3.32%	-0.07%	6.3分
15	云南白药	-3.54%	-4.35%	6.0分
16	济川药业	-3.77%	-4.36%	5.9分
17	华神科技	-4.41%	-4.18%	5.0分
18	康恩贝	-4.46%	-2.51%	4.7分
19	ST香雪	-5.02%	-1.28%	4.3分
20	古汉医药	-5.11%	-3.14%	5.6分
21	中恒集团	-5.41%	-4.30%	4.6分
22	太龙药业	-5.66%	-5.79%	5.1分
23	亚宝药业	-5.67%	-2.92%	5.7分
24	天士力	-5.87%	-2.27%	5.7分
25	仁和药业	-6.07%	-3.13%	4.8分
26	马应龙	-6.54%	-2.06%	5.4分
27	步长制药	-6.59%	-4.97%	5.7分
28	维康药业	-6.61%	-1.69%	4.5分
29	片仔癀	-6.66%	-3.09%	5.0分
30	众生药业	-6.99%	-2.93%	5.3分
31	同仁堂	-7.33%	-5.09%	4.9分
32	益盛药业	-7.39%	-4.78%	5.1分
33	信邦制药	-7.42%	-4.59%	5.0分
34	金花股份	-8.00%	-3.38%	5.7分
35	佛慈制药	-8.08%	-5.03%	5.3分
36	吉林敖东	-8.34%	-5.06%	5.3分
37	红日药业	-8.42%	-3.71%	5.2分
38	以岭药业	-8.58%	-3.68%	5.1分
39	康缘药业	-8.74%	-6.00%	5.1分
40	昆药集团	-8.84%	-5.70%	5.1分
41	康美药业	-8.90%	-5.43%	5.1分
42	新天药业	-9.00%	-5.13%	5.0分
43	新光药业	-9.48%	-5.99%	5.0分
44	益佰制药	-9.56%	-4.65%	4.7分
45	白云山	-9.60%	-9.60%	5.3分
46	精华制药	-9.92%	-7.17%	5.1分
47	广誉远	-10.01%	-4.78%	5.0分
48	奇正藏药	-10.05%	-5.53%	5.5分
49	寿仙谷	-10.32%	-4.79%	4.8分
50	太极集团	-10.68%	-3.44%	5.3分
51	千金药业	-10.90%	-6.80%	5.7分
52	佐力药业	-10.91%	-5.86%	5.4分
53	上海凯宝	-11.21%	-5.71%	4.7分
54	陇神戎发	-11.31%	-4.95%	5.2分
55	华森制药	-11.78%	-4.70%	5.2分
56	三力制药	-11.93%	-5.85%	5.4分
57	ST葫芦娃	-12.25%	-6.03%	4.6分
58	方盛制药	-12.75%	-5.59%	5.7分
59	沃华医药	-13.09%	-6.86%	5.8分
60	特一药业	-13.30%	-2.37%	5.8分
61	盘龙药业	-13.78%	-3.73%	5.6分
62	恩威医药	-13.99%	-6.44%	5.6分
63	葵花药业	-14.28%	-2.60%	4.4分
64	汉森制药	-14.80%	-6.36%	5.1分
65	珍宝岛	-14.82%	-4.34%	4.8分
66	-	-15.28%	-3.41%	分
67	-	-16.27%	-5.47%	分
68	粤万年青	-17.54%	-5.27%	5.4分
69	长药退	-55.17%	-57.61%	3.9分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.3基本面打败了27%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（30分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 60/108 ， 44/108。

[{"date":"2025-09-30","value":"-2.51","vol":"4.74"},{"date":"2025-06-30","value":"-2.91","vol":"3.98"},{"date":"2025-03-31","value":"-2.75","vol":"2.21"},{"date":"2024-12-31","value":"-18.98","vol":"4.80"},{"date":"2024-09-30","value":"-4.01","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-2.51	-2.91	-2.75	-18.98	-4.01
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"46.67","vol":"52.48"},{"date":"2025-06-30","value":"44.93","vol":"53.04"},{"date":"2025-03-31","value":"47.45","vol":"53.56"},{"date":"2024-12-31","value":"46.81","vol":"52.79"},{"date":"2024-09-30","value":"46.21","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	46.67	44.93	47.45	46.81	46.21
行业(%)	52.48	53.04	53.56	52.79	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/108 ， 15/108。

[{"date":"2025-09-30","value":"3.97","vol":"-7.63"},{"date":"2025-06-30","value":"-2.87","vol":"-7.68"},{"date":"2025-03-31","value":"-15.40","vol":"-7.53"},{"date":"2024-12-31","value":"-15.18","vol":"-7.39"},{"date":"2024-09-30","value":"-21.26","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	3.97	-2.87	-15.40	-15.18	-21.26
行业(%)	-7.63	-7.68	-7.53	-7.39	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"47.91","vol":"-2.70"},{"date":"2025-06-30","value":"26.61","vol":"2.90"},{"date":"2025-03-31","value":"-96.23","vol":"-37.21"},{"date":"2024-12-31","value":"-596.98","vol":"-146.29"},{"date":"2024-09-30","value":"-542.52","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	47.91	26.61	-96.23	-596.98	-542.52
行业(%)	-2.70	2.90	-37.21	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 53/108 ， 51/108。

[{"date":"2025-09-30","value":"0.23","vol":"0.35"},{"date":"2025-06-30","value":"0.14","vol":"0.24"},{"date":"2025-03-31","value":"0.06","vol":"0.12"},{"date":"2024-12-31","value":"0.32","vol":"0.50"},{"date":"2024-09-30","value":"0.19","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.23	0.14	0.06	0.32	0.19
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.00","vol":"1.72"},{"date":"2025-06-30","value":"0.62","vol":"1.18"},{"date":"2025-03-31","value":"0.27","vol":"0.60"},{"date":"2024-12-31","value":"1.43","vol":"2.41"},{"date":"2024-09-30","value":"0.84","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.00	0.62	0.27	1.43	0.84
行业(次)	1.72	1.18	0.60	2.41	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"2.65","vol":"9.43"},{"date":"2025-06-30","value":"109.74","vol":"20.06"},{"date":"2025-03-31","value":"-82.48","vol":"-0.30"},{"date":"2024-12-31","value":"2.74","vol":"15.76"},{"date":"2024-09-30","value":"2.60","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	2.65	109.74	-82.48	2.74	2.60
行业	9.43	20.06	-0.30	15.76	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.62","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.07","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.62	-	1.07	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/108 ， 37/108。

[{"date":"2025-09-30","value":"2.65","vol":"3.05"},{"date":"2025-06-30","value":"2.12","vol":"2.90"},{"date":"2025-03-31","value":"2.02","vol":"2.99"},{"date":"2024-12-31","value":"2.12","vol":"2.88"},{"date":"2024-09-30","value":"2.22","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.65	2.12	2.02	2.12	2.22
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.81","vol":"2.21"},{"date":"2025-06-30","value":"1.49","vol":"2.13"},{"date":"2025-03-31","value":"1.47","vol":"2.22"},{"date":"2024-12-31","value":"1.56","vol":"2.11"},{"date":"2024-09-30","value":"1.51","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.81	1.49	1.47	1.56	1.51
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 17/108 ， 25/108。

[{"date":"2025-09-30","value":"38.04","vol":"33.12"},{"date":"2025-06-30","value":"42.14","vol":"33.87"},{"date":"2025-03-31","value":"42.76","vol":"33.29"},{"date":"2024-12-31","value":"40.67","vol":"34.05"},{"date":"2024-09-30","value":"36.77","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	38.04	42.14	42.76	40.67	36.77
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.62","vol":"0.75"},{"date":"2025-06-30","value":"0.73","vol":"0.74"},{"date":"2025-03-31","value":"0.75","vol":"0.72"},{"date":"2024-12-31","value":"0.69","vol":"0.75"},{"date":"2024-09-30","value":"0.59","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.62	0.73	0.75	0.69	0.59
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"0.35","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.18","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.25","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.25","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[古汉医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]